Multicenter Exploratory Trial of the Safety and Efficacy of Adjuvant Docetaxel and Carboplatin in Patients With Resected Non-small Cell Lung Cancer
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Febrile neutropenia
2 months
Yes
David Jablons, MD
Principal Investigator
Maestro Clinical
United States: Institutional Review Board
MC#08-002
NCT00883675
May 2009
December 2012
Name | Location |
---|---|
Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire 03756 |